Astrocyte transplant derived from human embryonic stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Astrocyte transplant derived from human embryonic stem cells, covering 2021-01-15 to 2021-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]